רמיפריל פלוס טבע   5 מג25 מג ישראל - עברית - Ministry of Health

רמיפריל פלוס טבע 5 מג25 מג

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

רמיפריל פלוס טבע   5 מג25 מג ישראל - עברית - Ministry of Health

רמיפריל פלוס טבע 5 מג25 מג

teva pharmaceutical industries ltd, israel - hydrochlorothiazide; ramipril - טבליה - ramipril 5 mg; hydrochlorothiazide 25 mg - ramipril and diuretics - ramipril and diuretics - essential hypertension. ramipril plus is indicated in patients whose blood pressure cannot be adequately lowered with ramipril alone.

בריקלין טורבוהלר ישראל - עברית - Ministry of Health

בריקלין טורבוהלר

teva pharmaceutical industries ltd, israel - terbutaline sulfate - אבקה לשאיפה - terbutaline sulfate 0.5 mg/dose - terbutaline - terbutaline - for the relief of bronchospasm in patients with reversible onbstructive airway disease, including asthma, chronic bronchitis and emphysema.

קסמיאול ישראל - עברית - Ministry of Health

קסמיאול

dexcel ltd, israel - betamethasone as dipropionate; calcipotriol as hydrate - ג'ל - betamethasone as dipropionate 0.5 mg / 1 g; calcipotriol as hydrate 50 mcg / 1 g - betamethasone - betamethasone - topical treatment of psoriasis vulgaris on the scalp and topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults 18 years of age and older.

פברזיים 35 מג ישראל - עברית - Ministry of Health

פברזיים 35 מג

sanofi israel ltd - agalsidase beta - אבקה להכנת תמיסה מרוכזת לעירוי - agalsidase beta 35 mg/vial - agalsidase beta - agalsidase beta - fabrazyme is indicated for use as long-term enzyme replacement therapy in patients with a confirmed diagnosis of fabry disease. (alfa - galactosidase a deficiency).

פרימולוט-נור ישראל - עברית - Ministry of Health

פרימולוט-נור

bayer israel ltd - norethisterone acetate - טבליה - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.

אסיוול 5 מג ישראל - עברית - Ministry of Health

אסיוול 5 מג

teva pharmaceutical industries ltd, israel - diazepam - טבליה - diazepam 5 mg - diazepam - diazepam - tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.

אסיול 2 מג ישראל - עברית - Ministry of Health

אסיול 2 מג

teva pharmaceutical industries ltd, israel - diazepam - טבליה - diazepam 2 mg - diazepam - diazepam - tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.

אסיול 10 מג ישראל - עברית - Ministry of Health

אסיול 10 מג

teva pharmaceutical industries ltd, israel - diazepam - טבליה - diazepam 10 mg - diazepam - diazepam - tension, anxiety, agitation due to acute alcohol withdrawal, adjunct for the relief of skeletal muscle spasm, convulsive disorders.

לוטמקס תרחיף ישראל - עברית - Ministry of Health

לוטמקס תרחיף

abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po